Patents by Inventor Burleigh M. Hutchins
Burleigh M. Hutchins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240091136Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesthetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: ApplicationFiled: November 21, 2023Publication date: March 21, 2024Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Patent number: 11844856Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesthetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: GrantFiled: June 21, 2021Date of Patent: December 19, 2023Assignee: TARIS Biomedical LLCInventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Publication number: 20210308039Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: ApplicationFiled: June 21, 2021Publication date: October 7, 2021Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Patent number: 11040005Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: GrantFiled: July 17, 2020Date of Patent: June 22, 2021Assignee: TARIS Biomedical LLCInventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Publication number: 20200405625Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: ApplicationFiled: July 17, 2020Publication date: December 31, 2020Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, Cheryl Larrivee-Elkins, Heejin Lee
-
Publication number: 20170290764Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesthetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: ApplicationFiled: June 26, 2017Publication date: October 12, 2017Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, Cheryl Larrivee-Elkins, Heejin Lee
-
Patent number: 9757546Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: GrantFiled: December 28, 2012Date of Patent: September 12, 2017Assignee: TARIS Biomedical LLCInventors: Karen Danielle Daniel, Burleigh M. Hutchins, Cheryl Larrivee-Elkins, Heejin Lee
-
Publication number: 20170095651Abstract: Ureteral stent devices having improved drug delivery capabilities are provided. The ureteral stent device includes a ureteral stent comprising two opposed ends, and a drug delivery component associated with at least one end of the ureteral stent. The drug delivery component includes a drug housing defining a drug reservoir containing a drug, wherein the drug housing is configured to release the drug in-vivo.Type: ApplicationFiled: October 14, 2016Publication date: April 6, 2017Inventors: Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee, Jim Boyko
-
Patent number: 9492266Abstract: Ureteral stent devices having improved drug delivery capabilities are provided. The ureteral stent device includes a ureteral stent comprising two opposed ends, and a drug delivery component associated with at least one end of the ureteral stent. The drug delivery component includes a drug housing defining a drug reservoir containing a drug, wherein the drug housing is configured to release the drug in-vivo.Type: GrantFiled: August 5, 2011Date of Patent: November 15, 2016Assignee: TARIS Biomedical LLCInventors: Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee, Jim Boyko
-
Publication number: 20150190347Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: ApplicationFiled: March 5, 2015Publication date: July 9, 2015Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Publication number: 20130158675Abstract: Ureteral stent devices having improved drug delivery capabilities are provided. The ureteral stent device includes a ureteral stent comprising two opposed ends, and a drug delivery component associated with at least one end of the ureteral stent. The drug delivery component includes a drug housing defining a drug reservoir containing a drug, wherein the drug housing is configured to release the drug in-vivo.Type: ApplicationFiled: August 5, 2011Publication date: June 20, 2013Applicant: TARIS BIOMEDICAL INC.Inventors: Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee, Jim Boyko
-
Patent number: 8343516Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: GrantFiled: June 28, 2010Date of Patent: January 1, 2013Assignee: TARIS Biomedical, Inc.Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Patent number: 8073548Abstract: The present invention provides, among other things, a sensor system, having (1) a sensor implanted in a body part of the subject, wherein the sensor has a first antenna, and (2) a sensor reader worn on the subject's body part, wherein the sensor reader has a band housing a second antenna, which is inductively coupled with the first antenna, for enabling the sensor reader to communicate with the sensor.Type: GrantFiled: August 24, 2004Date of Patent: December 6, 2011Assignee: Sensors for Medicine and Science, Inc.Inventors: Arthur E. Colvin, Jr., Benjamin N. McLeod, Casey J. O'Connor, Burleigh M. Hutchins, Colleen Shannon
-
Publication number: 20100330149Abstract: A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.Type: ApplicationFiled: June 28, 2010Publication date: December 30, 2010Applicant: TARIS Biomedical, Inc.Inventors: Karen Danielle Daniel, Burleigh M. Hutchins, III, Cheryl Larrivee-Elkins, Heejin Lee
-
Patent number: 7092839Abstract: A system for managing and reporting laboratory data wherein the data is obtained at remote data-taking stations, transferred instantaneously by wireless communication to a main data-storing/manipulating station for recording therein without being recorded at the remote data-taking stations, and reported only from the data-storing/manipulating.Type: GrantFiled: July 26, 2002Date of Patent: August 15, 2006Assignee: VelQuest CorporationInventors: William Buote, Kenneth N. Rapp, Burleigh M. Hutchins
-
Patent number: 6681198Abstract: A system for securing and validating the management and reporting of laboratory data wherein the taking of data at remote data-taking stations is denied absent electronic verification of both equipment and individual qualification, and wherein access to the data is denied absent electronic verification of individual authority.Type: GrantFiled: August 16, 2001Date of Patent: January 20, 2004Assignee: VelQuest CorporationInventors: William Buote, Kenneth N. Rapp, Burleigh M. Hutchins
-
Patent number: 6581020Abstract: A system for managing and reporting laboratory data wherein the data is obtained at remote data-taking stations, transferred instantaneously by wireless communication to a main data-storing/manipulating station for recording therein without being recorded at the remote data-taking stations, and reported only from the data-storing/manipulating.Type: GrantFiled: October 10, 2000Date of Patent: June 17, 2003Assignee: VelQuest CorporationInventors: William Buote, Kenneth N. Rapp, Burleigh M. Hutchins
-
Publication number: 20020193966Abstract: A system for managing and reporting laboratory data wherein the data is obtained at remote data-taking stations, transferred instantaneously by wireless communication to a main data-storing/manipulating station for recording therein without being recorded at the remote data-taking stations, and reported only from the data-storing/manipulating.Type: ApplicationFiled: July 26, 2002Publication date: December 19, 2002Applicant: VelQuest CorporationInventors: William Buote, Kenneth N. Rapp, Burleigh M. Hutchins
-
Publication number: 20020077785Abstract: A system for securing and validating the management and reporting of laboratory data wherein the taking of data at remote data-taking stations is denied absent electronic verification of both equipment and individual qulification, and wherein access to the data is denied absent electronic verifiaction of individual authority.Type: ApplicationFiled: August 16, 2001Publication date: June 20, 2002Applicant: VelQuest CorporationInventors: William Buote, Kenneth N. Rapp, Burleigh M. Hutchins
-
Patent number: 6318594Abstract: A soft container and handling system for transporting, handling, and dispensing flowable dry goods, the container having a resealable discharge chute extending from a bottom wall portion and arranged to allow gravity induced discharge of goods when raised above a surface and to be closed against an upper portion of the container to prevent flow with the container supported on the surface.Type: GrantFiled: May 8, 2000Date of Patent: November 20, 2001Inventor: Burleigh M. Hutchins